Scheduled Conference Calls, License Agreements, Dividends, Preliminary Proxy statements and Initiation of Clinical Studies - Analyst Notes on Merck, Johnson & Johnson, AbbVie, Valeant and GSK
PR Newswire - 46 mins ago
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Johnson & Johnson (NYSE: JNJ), AbbVie Inc (NYSE: ABBV), Valeant Pharmaceuticals Intl Inc (NYSE: VRX) and GlaxoSmithKline plc (ADR) (NYSE: GSK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/4237-100free.
World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) 2013-2017
M2 - 2 hrs 20 mins ago
Research and Markets (http://www.researchandmarkets.com/research/4h95wb/the_world_market) has announced the addition of the "The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)" report to their offering. The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body by surgical instruments. In most instances, a catheter is a thin, flexible tube, though there is great diversity in catheter types and applications. This report provides descriptions of the types of catheters and estimates their market size and discusses the competitive activity in each category. Among the catheters used in urological applications are the Foley and the urethral catheters. Cardiovascular catheters find use in cardiac catheterization. This is a minimally invasive procedure in which a catheter is guided into the heart, usually through a blood vessel in the leg or arm. Once inside the heart, it can be used for diagnosing or treating a condition. Intravenous catheters are used if a person requires frequent or continuous injections of medications or fluids for nutritional support. A wound drain catheter is inserted while a patient is in the operating room receiving general anesthesia. The purpose of the drain is to remove fluid or blood from the surgical site. This helps the healing process. Increased life expectancy and subsequent aging of the global population play a key role in the rising demand for all types of medical catheters. Companies seeking opportunities in this medical device market will want to utilize on the World Market for Catheters. This report is a comprehensive look at the market of these critical medical devices. Which segments of catheters provide the most opportunity? Which are growing the fastest? Who are the key players and what share do they have of the market? What are the critical issues and trends that will drive catheter sales in the future. What pitfalls do manufacturers need to be aware of? These questions and more are answered in this report. This report contains global market size and forecast to 2017 for the following types of catheters: - Foley Catheters - Urethral Catheters - PTCA Catheters - Atherectomy Catheters - Ablation Catheters - Cardiac Angiography Catheters Peripheral Angiography Catheters - Implantable Ports - Central Venous Catheters Peripheral Insertion Catheters - Peripherally Inserted Central Catheters - Peripheral Insertion Midline Catheters - Oximetry Catheters - Thermodilution Catheters Suction Catheters Wound Drainage Catheters Company profiles are included, with profiles of the following companies: - Abbott - Angio Dynamics - Atrium Medical - Bactiguard AB - C.R. Bard - Becton Dickinson - Boston Scientific - B. Braun Melsungen - Cardinal Health - Carmeda - Cook Group - Catheter Research Inc. - Edwards Lifesciences - Greatbatch Medical - Johnson & Johnson - Hansen Medical - Iapyx Medical - Integra LifeSciences Holdings - Irvine Scientific - Medtronic - Medcomp - Siemens Medical Solutions - Smiths Medical - St. Jude Medical - Teleflex Medical Company - Terumo - Vascular Solutions - Vesta Inc - Zimmer Holdings For more information visit http://www.researchandmarkets.com/research/4h...rld_market
Johnson & Johnson Is a Boring Stock That Pays You to Wait
Zach Friesner, The Motley Fool - Motley Fool - Sun Jun 29, 8:13PM CDT
Foolish investors should love boring stocks because they make great candidates for long-term investments. These kinds of companies are in easy to understand lines of business, in stable industries, and usually have proven track records of...
3 Ways to Invest in This 43% Annual Growth Market
Leo Sun, The Motley Fool - Motley Fool - Sun Jun 29, 8:30AM CDT
Apple , Samsung , and Google recently teased us with glimpses of wearable health monitoring networks that will connect wearable devices, medical devices, and tracking apps to the smartphone via the cloud. Other smaller companies -- like...
Final Glance: Pharmaceuticals companies
AP - Fri Jun 27, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
Final Glance: Medical Devices companies
AP - Fri Jun 27, 5:02PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
Should Dividend Investors Eject Johnson & Johnson?
David Williamson, The Motley Fool - Motley Fool - Fri Jun 27, 4:00PM CDT
Healthcare conglomerate Johnson & Johnson is many things, a dividend aristocrat, a blue chip stock, and a Dow component, but does that make it one of the sector's top dividend stocks? In this video, Motley Fool Healthcare analyst David...
3 Reasons Why Johnson & Johnson Is a Better Dividend Stock Than AT&T
Anders Bylund, The Motley Fool - Motley Fool - Fri Jun 27, 1:00PM CDT
The Dow Jones Industrial Average is fertile ground for income investors. All 30 of its components today offer a dividend, with an average yield around 2.7%. Compare this to the broader S&P 500 index, where a still-impressive 424 out of 500...
Midday Glance: Pharmaceuticals companies
AP - Fri Jun 27, 12:33PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Fri Jun 27, 12:33PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Bristol-Myers, Pfizer, Regeneron Drugs Get EU Nods
at Investor's Business Daily - Fri Jun 27, 10:50AM CDT
Several key drugs from major drugmakers got endorsements from the European Medicines Agency (EMA) Friday, making commercial approval in the European Union's enormous market much more likely. Bristol-Myers Squibb's (BMY) hepatitis C drug daclatasvir,...
Early Glance: Medical Devices companies
AP - Fri Jun 27, 9:26AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Fri Jun 27, 9:26AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020
M2 - Fri Jun 27, 7:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9xm2bw/global_in_vitro) has announced the addition of the "Global In Vitro Diagnostics (IVD) Market (Technique, Product, Usability, Application, End User, and Geography) - Forecast to 2020" report to their offering. According to this research report titled "In Vitro Diagnostics Market (Techniques, Product Type, Usability, Applications, End-Users, Geography) - Industry Analysis, Trends, Share, Opportunities and Forecast, 2013 - 2020," the global In Vitro Diagnostics market has a potential to reach $74.46 billion by 2020 with North America being the largest regional market. North America is forecast to reach $30.1 billion by 2020 growing at a CAGR of 4.02% during 2014-2020. Asia-Pacific is forecast to be the fastest growing market and is expected to grow at a CAGR of 7.49% during the forecast period (from 2014 to 2020). The IVD market is evolving in the emerging markets due to widespread healthcare awareness and increased spending capabilities of people on healthcare. In addition, high demand of technologically advanced equipment for the early and precise diagnosis of various diseases is further strengthening the market growth in such regions. Key Topics Covered: CHAPTER 1 INTRODUCTION CHAPTER 2 EXECUTIVE SUMMARY CHAPTER 3 MARKET OVERVIEW CHAPTER 4 GLOBAL IVD MARKET BY TECHNIQUES CHAPTER 5 GLOBAL IVD MARKET BY PRODUCT TYPE CHAPTER 6 GLOBAL IVD MARKET BY USABILITY CHAPTER 7 GLOBAL IVD MARKET BY APPLICATION CHAPTER 8 GLOBAL IVD MARKET BY END USERS CHAPTER 9 GLOBAL IVD MARKET BY GEOGRAPHY CHAPTER 10 COMPANY PROFILES Companies Mentioned: - Abbot Laboratories - Alere Inc - Arkray Inc - Bayer AG - Becton Dickinson & Company - Biomerieux - Dahaner Corporation - Johnson & Johnson - Roche Diagnostics - Siemens - Sysmex Corp. For more information visit http://www.researchandmarkets.com/research/9x...l_in_vitro
Sarcoidosis - Pipeline Review, H1 2014
M2 - Fri Jun 27, 5:19AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jcs88c/sarcoidosis) has announced the addition of the "Sarcoidosis - Pipeline Review, H1 2014" report to their offering. This report provides comprehensive information on the therapeutic development for Sarcoidosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Sarcoidosis and special features on late-stage and discontinued projects. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Sarcoidosis - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Sarcoidosis pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline Companies Mentioned: - Johnson & Johnson - Pfizer Inc. - Celgene Corporation - Therametrics holding AG - PharmaIN Corporation For more information visit http://www.researchandmarkets.com/research/jc...arcoidosis
US Wound Care Market Trends Forecast Through 2019
M2 - Fri Jun 27, 5:02AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c98bcn/us_wound_care) has announced the addition of the "US Wound Care Market Trends Forecast Through 2019" report to their offering. The Market Intelligence report provides critical market data for US wound care market and its product categories. The data includes market size in terms of value and volume; average selling price for each product type, growth trends and market shares of companies at sector and category level. It's vital cross category comparison and cross sub-category comparison section makes analysis very handy for company professionals. The report helps professionals in mapping market size, competition, understanding historic and future growth trends. It covers important categories such as traditional wound care, wound dressings, negative pressure wound therapy (NPWT), wound closure devices, ostomy bags, compression therapy. Key Topics Covered: 1 Table of Contents 2 Introduction 3 Scope of the Report 4 US Market for Wound Care (2006-2019) 5 US Market for Traditional Wound Care (2006-2019) 6 US Market for Wound Dressings (2006-2019) 7 US Market for Negative Pressure Wound Therapy (NPWT) (2006-2019) 8 US Market for Wound Closure Devices (2006-2019) 9 US Market for Ostomy (2006-2019) 10 US Market for Compression Therapy (2006-2019) 11 Recent Events and Developments 12 Appendix Companies Mentioned: - 3M Health Care - Advanced Medical Solutions Group Plc - B. Braun Melsungen AG - Baxter International Inc. - BSN medical GmbH - Coloplast A/S - ConvaTec - Covidien Ltd. - Ethicon, Inc. - Hartmann Group - Hollister Incorporated - Johnson & Johnson - Kinetic Concepts, Inc. - Nycomed International Management GmbH - Smith & Nephew Plc For more information visit http://www.researchandmarkets.com/research/c9...wound_care
How America's 5 Biggest Pharma Stocks Stack up
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Thu Jun 26, 4:00PM CDT
For new health care investors particularly, America's five largest pharma stocks ( Johnson & Johnson , Pfizer , Merck , Bristol-Myers Squibb , and Eli Lilly ) are a good place to start. So, how do they stack up? in the video below,...